SNAP5089

Description

SNAP5089 is a selective ?1A-adrenoceptor antagonist with over 1700-fold selectivity for the ?1A subtype, which may have implications for the treatment of hypertension and benign prostatic hypertrophy. SNAP5089 demonstrates significant receptor affinity compared to other clinical drugs, emphasizing its potential therapeutic advantages. SNAP5089s high affinity aligns with its suitability for conditions where precise ?1A modulation is desirable.